Syndax’s leadership in menin inhibition and CSF-1R inhibition – – Revumenib abstracts showcase compelling results in multiple acute leukemia subtypes across the R/R, frontline, and post-HSCT setting – ...

Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious ...

Deutsche Telekom is making a major push into artificial intelligence (AI) infrastructure, teaming up with US chipmaker Nvidia ...

The new Gemini feature is helpful for both professionals and creators who often find themselves making Google Slides ...

Two oral and seven poster presentations further support the CARVYKTI® research in multiple myeloma First-in-Human Phase 1 ...

Incyte (Nasdaq:INCY) today announced that data from key programs in its oncology portfolio will be presented in both oral and poster sessions at the 2025 American Society of Hematology (ASH) Annual ...

(Terns or the Company) (Nasdaq: TERN), a clinical stage oncology company, today announced that data from the ongoing CARDINAL trial of TERN-701, a novel investigational allosteric BCR::ABL1 inhibitor, ...

Broad development program assesses ziftomenib across diverse AML segments and treatment paradigms to inform appropriate use - SAN DIEGO and TOKYO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc.

Explore NotebookLM's new features, including deep research mode and data tables, designed to simplify research and improve ...

AI carries a critical undertone that shapes every institution in the country, highlighting the urgency of addressing this ...

At AdWeek 2025’s Future Is Female Awards, we celebrated women leading lasting change — including Madeline Di Nonno, President ...

Two municipalities are considering building data centers. Janesville and the Village of DeForest held meetings on Tuesday night.